Revalesio Corporation is a pioneering biotechnology company based in Tacoma, Washington, dedicated to improving health.

Our goal is to maximize the benefits of our novel technology by developing products that represent a potential new class of treatments for inflammatory mediated diseases. To that end, Revalesio is partnering with leaders in biomedical research as well as non-profit organizations, to help us accelerate the adoption of this remarkable discovery.